Company page

Mimedx Group, Inc

Mimedx Group, Inc. (ticker: MDXG) is a public company based in the United States, specializing in regenerative medicine and advanced wound care products. With a market capitalization of approximately $625.6 million, Mimedx focuses on developing and commercializing innovative therapies to improve patient outcomes. The company's commitment to research and development positions it as a key player in the healthcare market.